HBMD Life Sciences operates as a seamless extension of your R&D team. Whether you need a quick feasibility study, a multi-month impurity isolation project, or end-to-end chemistry outsourcing — our chemists deliver regulatory-grade work under signed confidentiality, tracked with weekly milestones and delivered with full spectral packages.
We partner with innovator pharma, generic formulators, biotech start-ups and academic collaborators — providing the bench-level execution, analytical depth and regulatory documentation every R&D engagement demands.
Start a CRO ProjectLiterature mining, retrosynthetic analysis, and feasibility-scale benchwork to de-risk your target molecule before committing to a route.
Yield improvement, solvent minimisation, impurity control and purity enhancement for smooth commercial-scale transfer.
Isolation, synthesis and ICH-grade characterisation of process, degradation and forced-degradation impurities.
HPLC, GC, LC-MS method development and validation to ICH Q2 standards, with full dossier-ready documentation.
Forced degradation under acid, base, oxidative, thermal and photolytic conditions — ICH Q1A-aligned stability studies.
Dossier-ready COAs, NMR/Mass/IR spectra, and ICH Q3A/Q3B impurity profiles for global regulatory submissions.
It's a project-management problem, a communication problem, and an audit problem. We handle all four — so your team can stay focused on what matters.